Ubiquitin and Cellular Regulation
泛素和细胞调节
基本信息
- 批准号:7644015
- 负责人:
- 金额:$ 0.8万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-07-01 至 2011-06-30
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
DESCRIPTION (provided by applicant): A FASEB Summer Conference entitled 'Ubiquitin and Cellular Regulation' will be held July 22 - 27, 2006, at Vermont Academy, Saxtons River, Vermont. This conference is held biennially and partial funding for the conference is requested for the next three conferences to be convened in 2006, 2008, and 2010. The conference is the leading and longest -standing meeting in the ubiquitin field. It has been held since 1989, when the number of investigators working on ubiquitin grew to a critical mass. The conference has evolved as the field has rapidly expanded to focus on the newest and most significant developments. The last several meetings were oversubscribed and successful; 73 - 99% of participants rated the last two meetings in the top 10% of meetings they had ever attended. Many speakers new to the field were included and the talks were shortened so that a wide range of new research could be presented. These conventions will be continued in 2006, anticipating that they will again be well received by speakers and non-speakers.
The field of ubiquitin and ubiquitin-like proteins continues to grow at a striking pace as individuals in other fields find a crucial role for ubiquitin, the ubiquitination machinery, and ubiquitin-binding proteins in their targets of study. In some cases, insights from new individuals have moved the whole field forward dramatically and these cases emphasize the importance of bringing people together at this type of meeting. The growing connections between ubiquitination and human disease are well recognized, and it is estimated that over 5% of mammalian genomes are devoted to ubiquitination. The meeting will highlight breaking advances both in the choice of invited speakers and in multiple talks selected from abstracts. Special attention will be made to give the floor to new, junior, and underrepresented groups of investigators. The location of the conference at a relatively remote school in Vermont encourages interaction among all participants and this conference has an outstanding tradition of intense poster sessions. Based on past years, the conference will be oversubscribed; however, to foster strong interactions between participants the conference is limited to 180 participants.
描述(由申请人提供):题为“泛素和蜂窝法规”的FASEB夏季会议将于2006年7月22日至27日在佛蒙特州萨克斯顿河的佛蒙特学院举行。这次会议每两年举行,并要求为会议提供部分资金,以便在2006年,2008年和2010年召集接下来的三场会议。该会议是在泛素蛋白领域举行的领先且最长的会议。 它自1989年以来就一直举行,当时从事泛素的研究人员的数量增加到临界质量。随着该领域的迅速扩展,专注于最新,最重要的发展,会议的发展。 最后几次会议超额认购和成功。 73-99%的参与者在他们参加过的会议的前两个会议中对最后两个会议进行了评价。 包括该领域新手的许多演讲者,并缩短了谈判,因此可以进行广泛的新研究。 这些惯例将在2006年继续,预计他们将再次受到演讲者和非说话者的欢迎。
泛素和泛素样蛋白的领域继续以惊人的速度增长,因为其他领域的个体在研究目标中发现了泛素,泛素化机制和泛素结合蛋白的至关重要的作用。在某些情况下,新个人的见解已经大大推动了整个领域的前进,这些案例强调了将人们聚集在这类会议上的重要性。 泛素化与人类疾病之间的关系日益增长,据估计,超过5%的哺乳动物基因组致力于泛素化。 这次会议将在选择被邀请的演讲者和从摘要中选择的多次演讲中重点介绍打破进步。 将特别注意将新的,初级和代表性不足的调查人员组合起来。 会议在佛蒙特州一所相对偏僻的学校的地点鼓励了所有参与者之间的互动,这次会议具有杰出的紧张海报会议传统。 根据过去的几年,会议将被超额认购;但是,为了培养参与者之间的牢固互动,会议仅限于180名参与者。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
KEITH D WILKINSON其他文献
KEITH D WILKINSON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('KEITH D WILKINSON', 18)}}的其他基金
Ubiquitin and regulation of prion induction by a short-lived protein
泛素和短寿命蛋白对朊病毒诱导的调节
- 批准号:
8536841 - 财政年份:2011
- 资助金额:
$ 0.8万 - 项目类别:
Ubiquitin and regulation of prion induction by a short-lived protein
泛素和短寿命蛋白对朊病毒诱导的调节
- 批准号:
8042325 - 财政年份:2011
- 资助金额:
$ 0.8万 - 项目类别:
Ubiquitin and regulation of prion induction by a short-lived protein
泛素和短寿命蛋白对朊病毒诱导的调节
- 批准号:
8725684 - 财政年份:2011
- 资助金额:
$ 0.8万 - 项目类别:
Ubiquitin and regulation of prion induction by a short-lived protein
泛素和短寿命蛋白对朊病毒诱导的调节
- 批准号:
8325025 - 财政年份:2011
- 资助金额:
$ 0.8万 - 项目类别:
Ubiquitin-Dependent Proteolysis: Specificity & Mechanism
泛素依赖性蛋白水解:特异性
- 批准号:
7933334 - 财政年份:2009
- 资助金额:
$ 0.8万 - 项目类别:
HTS for Inhibitors of BAP1,BRCA:Deubiquinating(RMI)
BAP1、BRCA 抑制剂的 HTS:去泛素化 (RMI)
- 批准号:
7058567 - 财政年份:2005
- 资助金额:
$ 0.8万 - 项目类别:
相似国自然基金
NudC在细胞初级纤毛生长调节中的作用及分子机制研究
- 批准号:31471259
- 批准年份:2014
- 资助金额:80.0 万元
- 项目类别:面上项目
溶血磷脂酸在心梗后心肌重塑中作用及受体调节信号研究
- 批准号:30170374
- 批准年份:2001
- 资助金额:18.0 万元
- 项目类别:面上项目
中枢神经生长调节的细胞和分子基础
- 批准号:39930090
- 批准年份:1999
- 资助金额:100.0 万元
- 项目类别:重点项目
相似海外基金
Cancer-based discovery of novel mechanisms of chromatin control
基于癌症的染色质控制新机制的发现
- 批准号:
10660680 - 财政年份:2023
- 资助金额:
$ 0.8万 - 项目类别:
UBR5's mechanisms of action in tumorigenesis and immunoregulation
UBR5在肿瘤发生和免疫调节中的作用机制
- 批准号:
10659844 - 财政年份:2023
- 资助金额:
$ 0.8万 - 项目类别:
The role of USP27X-Cyclin D1 axis in HER2 Therapy Resistant Breast Cancer
USP27X-Cyclin D1 轴在 HER2 治疗耐药乳腺癌中的作用
- 批准号:
10658373 - 财政年份:2023
- 资助金额:
$ 0.8万 - 项目类别:
Mechanisms of Toxicity Induced by EWS/FLI1 Overdose in Ewing Sarcoma
EWS/FLI1 过量引起尤文肉瘤的毒性机制
- 批准号:
10719095 - 财政年份:2023
- 资助金额:
$ 0.8万 - 项目类别:
Understand Non-canonical RAS Signaling in Clonal Hematopoietic Disorders
了解克隆性造血疾病中的非典型 RAS 信号转导
- 批准号:
10571352 - 财政年份:2023
- 资助金额:
$ 0.8万 - 项目类别: